Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 9,19 M
EBIT 2017 -22,1 M
Net income 2017 -23,6 M
Debt 2017 -
Yield 2017 -
Sales 2018 18,9 M
EBIT 2018 -16,1 M
Net income 2018 -17,1 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 1,32x
Capi. / Sales2018 0,64x
Capitalization 12,2 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company. that engages in the developement of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell... 
Sector
Medical Equipment, Supplies & Distribution
Calendar

- No events available -

More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
08/11 CYTORI THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
08/11 CYTORI THERAPEUTICS INC (NASDAQ : CYTX) reported earnings of ($0.19) per share b..
08/10 CYTORI THERAPEUTICS : reports 2Q loss
08/10 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Results of Operations and..
08/10 CYTORI THERAPEUTICS, INC. : Results of Operations and Financial Condition, Finan..
08/10 CYTORI THERAPEUTICS INC : Investor Network: Cytori Therapeutics, Inc. to Host Ea..
08/10 Cytori Reports Second Quarter 2017 Business and Financial Results
08/04 Cytori to Webcast Second Quarter Financial Results on August 10
07/25 Cytori Therapeutics Announces Inducement Grants for New Employees
07/25 CYTORI THERAPEUTICS INC : Today's Research Reports on Stocks to Watch: Cytori Th..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second-q..
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second q..
07/28 Tech sector depresses European shares on busy earnings day
07/28 ESSILOR INTERNATIONAL : sticks to profitability target despite dip in sunglasses..
07/27 SMITH & NEPHEW : buoyed by double-digit emerging markets growth
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
2016 Cytori Therapeutics EPS in-line, beats on revenue
2016 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
2016 Notable earnings after Tuesday?s close
2016 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2,17 $
Spread / Average Target 519%
EPS Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS INC-4.14%12
MEDTRONIC PLC18.76%114 960
BAXTER INTERNATIONAL37.12%33 128
C R BARD INC42.81%23 315
ZIMMER BIOMET HOLDINGS INC9.47%22 842
HOYA CORPORATION29.57%22 449